128 related articles for article (PubMed ID: 35405479)
1. A pilot randomised controlled trial of abrupt versus gradual smoking cessation in combination with vaporised nicotine products for people receiving alcohol and other drug treatment.
Skelton E; Lum A; Robinson M; Dunlop A; Guillaumier A; Baker A; Gartner C; Borland R; Clapham M; Bonevski B
Addict Behav; 2022 Aug; 131():107328. PubMed ID: 35405479
[TBL] [Abstract][Full Text] [Related]
2. Barriers and facilitators to using vaporised nicotine products as smoking cessation aids among people receiving treatment for substance use disorder.
Lum A; Skelton E; Robinson M; Guillaumier A; Wynne O; Gartner C; Borland R; Baker A; Dunlop A; Wilkinson RB; Bonevski B
Addict Behav; 2022 Jan; 124():107097. PubMed ID: 34536632
[TBL] [Abstract][Full Text] [Related]
3. Electronic nicotine devices to aid smoking cessation by alcohol- and drug-dependent clients: protocol for a pilot randomised controlled trial.
Guillaumier A; Manning V; Wynne O; Gartner C; Borland R; Baker AL; Segan CJ; Skelton E; Moore L; Bathish R; Lubman DI; Bonevski B
Trials; 2018 Aug; 19(1):415. PubMed ID: 30071863
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial.
Howard BC; McRobbie H; Petrie D; Barker D; Mendelsohn C; Anderson J; Borland R; Naughton F; Tutka P; Zwar N; Boland VC; Aiken A; Shakeshaft A; Gartner C; Richmond RL; Hall W; Mattick RP; Farrell M; Courtney RJ
Trials; 2022 Sep; 23(1):777. PubMed ID: 36104702
[TBL] [Abstract][Full Text] [Related]
5. Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): The Study Protocol of an Uncontrolled Feasibility Study of Novel Nicotine Replacement Products among People Living with HIV Who Smoke.
Bell S; Dean J; Gilks C; Boyd MA; Fitzgerald L; Mutch A; Baker P; Neilsen G; Gartner CE
Int J Environ Res Public Health; 2017 Jul; 14(7):. PubMed ID: 28718828
[TBL] [Abstract][Full Text] [Related]
6. Study protocol for a randomised controlled trial of electronic cigarettes versus nicotine patch for smoking cessation.
Bullen C; Williman J; Howe C; Laugesen M; McRobbie H; Parag V; Walker N
BMC Public Health; 2013 Mar; 13():210. PubMed ID: 23496861
[TBL] [Abstract][Full Text] [Related]
7. A Single-Arm, Open-Label, Pilot, and Feasibility Study of a High Nicotine Strength E-Cigarette Intervention for Smoking Cessation or Reduction for People With Schizophrenia Spectrum Disorders Who Smoke Cigarettes.
Caponnetto P; DiPiazza J; Kim J; Maglia M; Polosa R
Nicotine Tob Res; 2021 Jun; 23(7):1113-1122. PubMed ID: 33723598
[TBL] [Abstract][Full Text] [Related]
8. QuitNic: A Pilot Randomized Controlled Trial Comparing Nicotine Vaping Products With Nicotine Replacement Therapy for Smoking Cessation Following Residential Detoxification.
Bonevski B; Manning V; Wynne O; Gartner C; Borland R; Baker AL; Segan CJ; Skelton E; Moore L; Bathish R; Chiu S; Guillaumier A; Lubman DI
Nicotine Tob Res; 2021 Feb; 23(3):462-470. PubMed ID: 32770246
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled trial of NRT-aided gradual vs. abrupt cessation in smokers actively trying to quit.
Hughes JR; Solomon LJ; Livingston AE; Callas PW; Peters EN
Drug Alcohol Depend; 2010 Sep; 111(1-2):105-13. PubMed ID: 20537810
[TBL] [Abstract][Full Text] [Related]
10. Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial.
Walker N; Parag V; Verbiest M; Laking G; Laugesen M; Bullen C
Lancet Respir Med; 2020 Jan; 8(1):54-64. PubMed ID: 31515173
[TBL] [Abstract][Full Text] [Related]
11. Vaporised nicotine and tobacco harm reduction for addressing smoking among people living with HIV: A cross-sectional survey of Australian HIV health practitioners' attitudes.
Bell SK; Mena G; Dean J; Boyd M; Gilks C; Gartner C
Drug Alcohol Depend; 2017 Aug; 177():67-70. PubMed ID: 28577393
[TBL] [Abstract][Full Text] [Related]
12. A Randomized Pilot of a Tailored Smoking Cessation Quitline Intervention for Individuals Who Smoke and Vape.
Vickerman KA; Carpenter KM; Miles LN; Hsu JM; Watt KA; Brandon TH; Hart JT; Javitz HS; Wagener TL
Nicotine Tob Res; 2022 Oct; 24(11):1811-1820. PubMed ID: 35575085
[TBL] [Abstract][Full Text] [Related]
13. Gradual Versus Abrupt Smoking Cessation: A Randomized, Controlled Noninferiority Trial.
Lindson-Hawley N; Banting M; West R; Michie S; Shinkins B; Aveyard P
Ann Intern Med; 2016 May; 164(9):585-92. PubMed ID: 26975007
[TBL] [Abstract][Full Text] [Related]
14. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
Wang D; Connock M; Barton P; Fry-Smith A; Aveyard P; Moore D
Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448
[TBL] [Abstract][Full Text] [Related]
15. Exploratory Analyses of the Popularity and Efficacy of Four Behavioral Methods of Gradual Smoking Cessation.
Lindson N; Michie S; Aveyard P
Nicotine Tob Res; 2020 Dec; 22(12):2257-2261. PubMed ID: 32609847
[TBL] [Abstract][Full Text] [Related]
16. Electronic cigarettes for smoking cessation and reduction.
McRobbie H; Bullen C; Hartmann-Boyce J; Hajek P
Cochrane Database Syst Rev; 2014; (12):CD010216. PubMed ID: 25515689
[TBL] [Abstract][Full Text] [Related]
17. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
[TBL] [Abstract][Full Text] [Related]
18. A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT.
Peckham E; Arundel C; Bailey D; Crosland S; Fairhurst C; Heron P; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C; Gilbody S
Health Technol Assess; 2019 Sep; 23(50):1-116. PubMed ID: 31549622
[TBL] [Abstract][Full Text] [Related]
19. Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial.
Gilbody S; Peckham E; Bailey D; Arundel C; Heron P; Crosland S; Fairhurst C; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C
Lancet Psychiatry; 2019 May; 6(5):379-390. PubMed ID: 30975539
[TBL] [Abstract][Full Text] [Related]
20. Proactive text messaging (GetReady2Quit) and nicotine replacement therapy to promote smoking cessation among smokers in primary care: A pilot randomized trial protocol.
Kruse GR; Park E; Haberer JE; Abroms L; Shahid NN; Howard SE; Chang Y; Haas JS; Rigotti NA
Contemp Clin Trials; 2019 May; 80():48-54. PubMed ID: 30923022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
